Fiberoptic probe safely monitors blood flow

Minimally invasive blood flow probe allows continuous monitoring (Pixabay)
Minimally invasive blood flow probe allows continuous monitoring (Pixabay)

Researchers at Flinders University in Australia are developing a fiberoptic probe that continuously monitors blood flow using optical heating. The probe reportedly provides a safer, minimally invasive method of measuring blood flow, during prolonged and often dangerous intensive care and surgical procedures, even in tiny patients.

"The minimally invasive device is suitable for neonates right through to adults," says research leader Strategic Professor John Arkwright, who has done considerable research in fiberoptic technologies for medical diagnostics. "It's a far more responsive measurement compared to traditional blood flow monitoring―and without life-threatening delays in the period 'snapshot' provided by current blood flow practices using ultrasound or thermo-dilution."

A fiber-optic probe under development at Flinders University in Australia promises to be a safer, minimally invasive method of sensing blood flow.
A fiber-optic probe under development at Flinders University in Australia promises
to be a safer, minimally invasive method of sensing blood flow. (Flinders University)

Neonatal expert and co-investigator Dr. Scott Morris, from the Flinders Medical Centre Neonatal Unit and Flinders University College of Medicine and Public Health, says the sensor-catheter device promises to deliver accurate blood flow information in critically ill patients, from pre-term babies to cardiac bypass patients.

Sponsored by Infosys

Infosys positioned as a Leader in Gartner Magic Quadrant for IT Services for Communications Service Providers, Worldwide 2020

The Gartner Magic Quadrant evaluated 12 vendors and Infosys was recognized for its completeness of vision and ability to execute.
Infosys leverages its global partner ecosystem, CSP-dedicated studio, design tools, and 5G Living Labs to boost service delivery. Innovative solutions such as the ‘Infosys Cortex2’ are driving business value for CSPs.

"This tiny device, which could even be used in pre-term infants, has the potential to be far superior to the intermittent measure of averaged blood flow delivered by traditional methods which generally only show time averaged flow every 30 minutes or so," Dr. Morris says.

A provisional patent has been filed for the device, which is seeking industry partners for further development.

Chief investigator Albert Ruiz-Vargas hopes the device will be picked up for further development and introduction into regular intensive care and surgical procedures.

"The proof-of-concept prototype is potentially a low-cost device which has passed initial testing in a heart-lung machine," Dr. Ruiz-Vargas says.

The scientists believe more research is required to determine how the sensor will behave under more physiological conditions and to examine different encapsulations to comply with human safety.

Suggested Articles

The world’s largest chipmaker saw a 47% decline in data center sales to enterprise and government, even as it forecast a full year 2020 record of $75B

Working with Jacoti of Belgium, Qualcomm wants to make earbuds recognize the hearing anomalies of users.

Deep learning is one of the most promising techniques for training machines to "think" like people.